Skip to content
WeighLab
Menu
Ranked #231 · Grade C

Longevixx review

Longevixx sells compounded semaglutide at a standing $199 a month and tirzepatide at $299, advertises $149 without saying it is a first-month discount, and names no pharmacy, clinician or medical group anywhere.

Visit Longevixx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199/mo month-to-month (charged every 30 days; the advertised $149 is the first month only)
Tirzepatide
$299/mo month-to-month (charged every 30 days)
Coverage
All 50 states
Brand-name
Compounded only

Semaglutide · modeled / year

$2,388

Tirzepatide · modeled / year

$3,588

Pricing verified September 2026

The Index scorecard

Longevixx scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month58/100
Price Transparency30/100
Nationwide Access86/100
Formulation Options77/100
Clinical Oversight60/100
Contract Flexibility61/100

Where the value is

  • The monthly figure covers the medication, physician review, care coaching, a dietitian visit and expedited shipping, with no separate consultation fee
  • Prices 19 peptide programs publicly alongside the GLP-1s
  • Cancellation is a switch in the patient portal, and an electronic notice arrives five to seven days before each charge
  • A low-dose GLP-1 at $129 and a daily oral GLP-1 at $229 are priced openly once the Other treatments control is opened

The tradeoffs

  • The advertised "from $149/mo" is a first-month price; the standing month-to-month rate is $199, and the checkout labels the difference "$50 off first month"
  • "Same price · All dosages · No hidden fees · Everything included" sits directly above a card whose price rises after the first month
  • No compounding pharmacy, medical group, clinician or NPI is named on any of the ten pages or 25 funnel screens read; 503A and 503B appear nowhere on the domain
  • There is no refund policy page and no general refund right — the only refund sentence in the terms covers a pricing error
  • Neither the low-dose program nor the oral program names its molecule on any surface, and the oral program has no public page at all
  • The checkout claims 24/7 access to the care team while the published clinical hours are Monday to Friday, 9 to 5
  • A North Carolina address, Delaware governing law and a Wilmington arbitration venue are published with no state of formation
  • Patient counts and ratings disagree across the site and the funnel, and no review platform is named for any of them

The bottom line

Best for: Readers who want a broad peptide catalog beside a GLP-1 and will check the second month's price before subscribing. Longevixx sells compounded semaglutide at a standing $199 a month and tirzepatide at $299, advertises $149 without saying it is a first-month discount, and names no pharmacy, clinician or medical group anywhere.

Ranked #231 of 529 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 528 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Longevixx.

The 24 programs nearest this one

Pricing, states and verification reflect Longevixx's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Longevixx's site. Not medical advice; see our disclosure.

← Back to the value leaderboard